What is BioTelemetry Interest Expense?
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. BioTelemetry's interest expense for the
three
months ended in Sep. 2020 was $ -0.9 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Sep. 2020 was $-6.8 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. BioTelemetry's Operating Income for the
three
months ended in Sep. 2020 was $ 21.5 Mil. BioTelemetry's Interest Expense for the
three
months ended in Sep. 2020 was $ -0.9 Mil.
BioTelemetry's Interest Coverage for the quarter that ended in Sep. 2020 was 23.88.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
BioTelemetry Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioTelemetry (NAS:BEAT) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
BioTelemetry's Interest Expense for the
three
months ended in Sep. 2020 was $-0.9 Mil. Its
Operating Income
for the
three
months ended in Sep. 2020 was $21.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Sep. 2020 was $158.1 Mil.
BioTelemetry's Interest Coverage for the quarter that ended in Sep. 2020 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
BioTelemetry (BioTelemetry) Business Description
Traded in Other Exchanges
N/A
Address
1000 Cedar Hollow Road, Suite 102, Malvern, PA, USA, 19355
BioTelemetry Inc provides monitoring services and digital population health management for healthcare providers, medical device manufacturing, and centralized core laboratory services for clinical research. It operates under healthcare, technology, and research segments. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials and the Technology segment, focuses on the development, manufacturing, testing, and marketing of cardiovascular and blood glucose monitoring devices to medical companies, clinics and hospitals.
Executives
| Kirk E Gorman |
director |
367 SOUTH GULPH ROAD, KING PRUSSIA PA 19406 |
| Stephen Rietiker |
director |
C/O BIOTELEMETRY, INC., 1000 CEDAR HOLLOW RD. SUITE 102, MALVERN PA 19355 |
| Tiffany Olson |
director |
C/O CASTLE BIOSCIENCES, INC., 505 S. FRIENDSWOOD DRIVE, SUITE 401, FRIENDSWOOD TX 77546 |
| Joseph A. Frick |
director |
ONE COMMERCE SQUARE 2005 MARKET ST., SUITE 3300 19103 PR 19073 |
| Laura N. Dietch |
director |
1000 CEDAR HOLLOW RD. SUITE 102 MALVERN PA 19355 |
| Anthony James Conti |
director |
76 GOLFVIEW DRIVE, IVYLAND PA 18974 |
| Rebecca W Rimel |
director |
345 PARK AVENUE, NEW YORK NY 10154 |
| Robert J. Rubin |
director |
7901 SPRINGER ROAD, BETHESDA MD 20817 |
| Hill Colin |
director |
196 BROADWAY CAMBRIDGE MA 02139 |
| Andrei G Stoica |
officer: SVP & CTO |
1000 CEDAR HOLLOW ROAD, MALVERN PA 19355 |
| Joseph H Capper |
director, officer: President & CEO |
BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355 |
| Manish Wadhwa |
officer: SVP & CMO |
1000 CEDAR HOLLOW ROAD MALVERN PA 19355 |
| Fred Broadway |
officer: President BioTel Heart |
BIOTELEMETRY, INC. 1000 CEDAR HOLLOW ROAD, #102 MALVERN PA 19355 |
| Daniel Wisniewski |
officer: SVP, Technical Operations |
BIOTELEMETRY, INC. 1000 CEDAR HOLLOW ROAD, #102 MALVERN PA 19355 |
| Heather C Getz |
officer: EVP, CFO & CAO |
BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355 |
BioTelemetry (BioTelemetry) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BEAT has been successfully added to your 